JPWO2020257707A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020257707A5
JPWO2020257707A5 JP2021576258A JP2021576258A JPWO2020257707A5 JP WO2020257707 A5 JPWO2020257707 A5 JP WO2020257707A5 JP 2021576258 A JP2021576258 A JP 2021576258A JP 2021576258 A JP2021576258 A JP 2021576258A JP WO2020257707 A5 JPWO2020257707 A5 JP WO2020257707A5
Authority
JP
Japan
Prior art keywords
residue
seq
residue corresponding
host cell
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021576258A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022537214A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/038813 external-priority patent/WO2020257707A1/en
Publication of JP2022537214A publication Critical patent/JP2022537214A/ja
Publication of JPWO2020257707A5 publication Critical patent/JPWO2020257707A5/ja
Pending legal-status Critical Current

Links

JP2021576258A 2019-06-21 2020-06-19 メープルシロップ尿症(msud)の処置のおける使用のための酵素の生合成 Pending JP2022537214A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962865129P 2019-06-21 2019-06-21
US201962864875P 2019-06-21 2019-06-21
US62/864,875 2019-06-21
US62/865,129 2019-06-21
PCT/US2020/038813 WO2020257707A1 (en) 2019-06-21 2020-06-19 Biosynthesis of enzymes for use in treatment of maple syrup urine disease (msud)

Publications (2)

Publication Number Publication Date
JP2022537214A JP2022537214A (ja) 2022-08-24
JPWO2020257707A5 true JPWO2020257707A5 (enExample) 2023-06-27

Family

ID=74037433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021576258A Pending JP2022537214A (ja) 2019-06-21 2020-06-19 メープルシロップ尿症(msud)の処置のおける使用のための酵素の生合成

Country Status (9)

Country Link
US (2) US20220348933A1 (enExample)
EP (2) EP3986432A4 (enExample)
JP (1) JP2022537214A (enExample)
KR (1) KR20220042350A (enExample)
CN (1) CN114450403A (enExample)
AU (1) AU2020297586A1 (enExample)
CA (1) CA3144416A1 (enExample)
IL (1) IL289123A (enExample)
WO (2) WO2020257610A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
US20220031771A1 (en) * 2020-07-31 2022-02-03 Iowa State University Research Foundation, Inc. Microencapsulated and chromosome integrated compositions for l-dopa microbiome therapy
CN113484435B (zh) * 2021-07-05 2023-04-07 中国人民解放军空军军医大学 检测血浆支链氨基酸和支链a酮酸水平的物质的应用及产品
WO2024064918A2 (en) * 2022-09-23 2024-03-28 Novome Biotechnologies, Inc. Recombinant fusion polypeptides for secreting soluble, heterologous cargo
WO2025046062A1 (en) 2023-08-31 2025-03-06 Snipr Biome Aps A novel type of crispr/cas system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6119738B2 (ja) * 2012-03-30 2017-04-26 味の素株式会社 改変ロイシン脱水素酵素
US10233467B2 (en) * 2012-08-17 2019-03-19 Easel Biotechnologies, Llc Two-stage production of higher alcohols
US10059969B1 (en) * 2014-10-03 2018-08-28 Abbvie Inc. Process for the preparation of (S)-2-amino-non-8-enoic acid
US10610546B2 (en) * 2015-05-13 2020-04-07 Synlogic Operating Company Inc. Bacteria engineered to reduce hyperphenylalaninemia
CN104774813B (zh) * 2015-04-20 2019-02-26 南京工业大学 一种亮氨酸脱氢酶及其制备方法和应用
EP3307870B1 (en) * 2015-06-10 2023-08-02 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acid
WO2017123676A1 (en) * 2016-01-11 2017-07-20 Synlogic, Inc. Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
CN108103038B (zh) * 2017-12-15 2021-03-02 江南大学 一种合成l-苯甘氨酸的单细胞工厂及其构建与应用
CN108559735B (zh) * 2018-05-10 2020-07-07 江南大学 一种亮氨酸脱氢酶突变体的构建及其应用
CN109321538A (zh) * 2018-09-07 2019-02-12 江南大学 一种基于数据库基因挖掘方法获得的亮氨酸脱氢酶
CN109679978B (zh) * 2018-12-12 2020-12-29 浙江工业大学 一种用于制备l-2-氨基丁酸的重组共表达体系及其应用
WO2021146394A1 (en) * 2020-01-14 2021-07-22 Synlogic Operating Company, Inc. Optimized bacteria engineered to treat disorders involving the catabolism of leucine, isoleucine, and/or valine

Similar Documents

Publication Publication Date Title
US20240158736A1 (en) Microorganisms and uses thereof
CN105543266A (zh) 一种维吉尼亚链霉菌IBL14中的CRISPR-Cas系统及应用其进行基因编辑的方法
CN108949869B (zh) 无碳源阻遏毕赤酵母表达系统、其建立方法及应用
JP2005500054A5 (enExample)
CN112458108A (zh) 一种在谷氨酸棒状杆菌中利用木糖生成谷氨酸的合成路径的构建方法
JPWO2021100640A5 (enExample)
CN101389750B (zh) 用于直接表达肽的改进的细菌宿主细胞
CN110885803A (zh) 重组草铵膦脱氢酶、基因工程菌及其在制备l-草铵膦中的应用
CN109971778B (zh) 一种在盐单胞菌中快速基因编辑的载体组合及其应用
JPWO2020257707A5 (enExample)
JP7092355B2 (ja) 増殖とタンパク質生成との分離
KR20170017415A (ko) 큐메이트 오페론에 의해 조절되는 유전자 발현용 카세트
CN107287144A (zh) 一种代谢改造的枯草芽孢杆菌生物转化细胞及其制备方法与应用
CN112029699B (zh) 一种基于内源CRISPR-Cas系统的丁酸梭菌基因编辑系统及其应用
JP5498651B2 (ja) ジピコリン酸又はその塩の製造方法
JPWO2004053111A1 (ja) 外来遺伝子高発現大腸菌株の選択方法、その方法により選択される大腸菌変異株及びそれを用いる酵素及び化合物の製造方法
CN107541482A (zh) 一种构建大肠杆菌高效分泌表达转肽酶Sortase A的方法
CN117106048A (zh) 一种提高植物遗传转化效率的新方法
CN107208106A (zh) 通过降低rnpA基因表达制备重组蛋白的方法
CN110878293B (zh) 缺失yceD基因的地衣芽胞杆菌在异源蛋白生产中的应用
CN114645049A (zh) 一种基于核心区二级结构改造提高启动子活性的方法和应用
US20210087586A1 (en) Method for counterselection in microorganisms
TWI697559B (zh) 穿梭載體、包含其之原核宿主細胞與試劑組以及利用該宿主細胞生產蛋白質之方法
CN106148350A (zh) 一种利用乳糖培养基高效表达家蚕重组抗菌肽的方法
JP2004512009A5 (enExample)